Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to $7.8 billion.

  • Sanofi's Other Non-Current Liabilities fell 980.26% to $7.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.8 billion, marking a year-over-year decrease of 980.26%. This contributed to the annual value of $7.6 billion for FY2025, which is 1355.23% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's Other Non-Current Liabilities is $7.8 billion, which was down 980.26% from $8.1 billion recorded in Q2 2025.
  • Sanofi's 5-year Other Non-Current Liabilities high stood at $8.9 billion for Q2 2024, and its period low was $1.3 billion during Q4 2022.
  • In the last 5 years, Sanofi's Other Non-Current Liabilities had a median value of $7.9 billion in 2025 and averaged $6.7 billion.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 2843.95% in 2021, then skyrocketed by 55020.06% in 2023.
  • Sanofi's Other Non-Current Liabilities (Quarter) stood at $1.3 billion in 2021, then decreased by 1.64% to $1.3 billion in 2022, then surged by 550.2% to $8.2 billion in 2023, then rose by 5.77% to $8.7 billion in 2024, then decreased by 9.8% to $7.8 billion in 2025.
  • Its Other Non-Current Liabilities stands at $7.8 billion for Q4 2025, versus $8.1 billion for Q2 2025 and $8.7 billion for Q4 2024.